← Eichor
Study identifier: NCT05215197 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Intracochlear Platelet-rich Fibrin Application in Cochlear Implantation

Condition: Hearing Loss, Sensorineural  ·  Sponsor: Pamukkale University

PhaseNA
Planned participants10
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

Fibrosis due to surgical trauma is a common problem with cochlear implants. Fibrosis limits the effectiveness of implant and increases the power consumption. Our aim in this study is to benefit from the anti-inflammatory effects of autologous platelet-rich fibrin to reducing the fibrotic cascade.

This description comes directly from the study's public registry record.

Talk to the study team

Fazil N Ardic, MD  ·  902582965799  ·  fnardic@pau.edu.tr

Always discuss trial participation with your own doctor first.

Locations (1)

Pamukkale UniversityDenizli, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05215197